Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arati Tripathi

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|July 26, 2020
Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase InhibitorElizabeth Terry-Kantor, Arati Tripathi, Thibaut Imberdis, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 28, 2022
Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid HomeostasisArati Tripathi, Heba Alnakhala, Elizabeth Terry-Kantor, et al.
ACS Omega|June 12, 2023
5-Nitro-1,2-benzothiazol-3-amine and <i>N</i>-Ethyl-1-[(ethylcarbamoyl)(5-nitro-1,2-benzothiazol-3-yl)amino]formamide Modulate α-Synuclein and Tau AggregationEduardo Ramirez, Susantha K Ganegamage, Ahmed A Elbatrawy, et al.
ACS Omega|January 15, 2024
1,4-Diurea- and 1,4-Dithiourea-Substituted Aromatic Derivatives Selectively Inhibit α-Synuclein Oligomer Formation <i>In Vitro</i>Susantha K Ganegamage, Eduardo Ramirez, Heba Alnakhala, et al.
ACS Omega|September 8, 2025
In Vitro Evaluation of Amide-Linked Coumarin Scaffolds for the Inhibition of α‑Synuclein and Tau AggregationTaiwo A Ademoye, Susantha K Ganegamage, Behrad Masoudi, et al.
NPJ Parkinson'S Disease|February 29, 2024
Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson's disease phenotypesSilke Nuber, Xiaoqun Zhang, Thomas D McCaffery, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Lipid droplets promote the aberrant liquid-liquid phase separation of alpha-synuclein leading to impaired energy homeostasisJose Cevallos, Elena Eubanks, Sunghoo Jung, et al.
NPJ Parkinson'S Disease|March 13, 2024
Author Correction: Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson's disease phenotypesSilke Nuber, Xiaoqun Zhang, Thomas D McCaffery, et al.
ACS Chemical Neuroscience|October 22, 2024
Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease TherapeuticsSusantha K Ganegamage, Taiwo A Ademoye, Henika Patel, et al.
ACS Chemical Neuroscience|October 11, 2023
Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on α-Synuclein and Tau AggregationEduardo Ramirez, Susantha K Ganegamage, Sehong Min, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|July 26, 2020
Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase InhibitorElizabeth Terry-Kantor, Arati Tripathi, Thibaut Imberdis, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 28, 2022
Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid HomeostasisArati Tripathi, Heba Alnakhala, Elizabeth Terry-Kantor, et al.
ACS Omega|June 12, 2023
5-Nitro-1,2-benzothiazol-3-amine and <i>N</i>-Ethyl-1-[(ethylcarbamoyl)(5-nitro-1,2-benzothiazol-3-yl)amino]formamide Modulate α-Synuclein and Tau AggregationEduardo Ramirez, Susantha K Ganegamage, Ahmed A Elbatrawy, et al.
ACS Omega|January 15, 2024
1,4-Diurea- and 1,4-Dithiourea-Substituted Aromatic Derivatives Selectively Inhibit α-Synuclein Oligomer Formation <i>In Vitro</i>Susantha K Ganegamage, Eduardo Ramirez, Heba Alnakhala, et al.
ACS Omega|September 8, 2025
In Vitro Evaluation of Amide-Linked Coumarin Scaffolds for the Inhibition of α‑Synuclein and Tau AggregationTaiwo A Ademoye, Susantha K Ganegamage, Behrad Masoudi, et al.
NPJ Parkinson'S Disease|February 29, 2024
Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson's disease phenotypesSilke Nuber, Xiaoqun Zhang, Thomas D McCaffery, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Lipid droplets promote the aberrant liquid-liquid phase separation of alpha-synuclein leading to impaired energy homeostasisJose Cevallos, Elena Eubanks, Sunghoo Jung, et al.
NPJ Parkinson'S Disease|March 13, 2024
Author Correction: Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson's disease phenotypesSilke Nuber, Xiaoqun Zhang, Thomas D McCaffery, et al.
ACS Chemical Neuroscience|October 22, 2024
Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease TherapeuticsSusantha K Ganegamage, Taiwo A Ademoye, Henika Patel, et al.
ACS Chemical Neuroscience|October 11, 2023
Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on α-Synuclein and Tau AggregationEduardo Ramirez, Susantha K Ganegamage, Sehong Min, et al.
Pageof 3